Stock Track | ORIC Pharmaceuticals Soars 9.17% Pre-Market as Jefferies Raises Price Target

Stock Track

Feb 19

ORIC Pharmaceuticals Inc. (ORIC) stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.

Jefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.

While the specific reasons behind Jefferies' price target increase were not disclosed, analysts typically adjust their ratings and price targets based on factors such as updated financial projections, clinical trial results, or other developments that could affect a company's future performance.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1133311511"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1133311511\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1133311511?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-19 22:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133311511","market":"us","top_or_hot":-1,"title":"Stock Track | ORIC Pharmaceuticals Soars 9.17% Pre-Market as Jefferies Raises Price Target","media":"Stock Track","content":"<p>ORIC Pharmaceuticals Inc. (ORIC) stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.</p>\n\n<p>Jefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.</p>\n\n<p>While the specific reasons behind Jefferies' price target increase were not disclosed, analysts typically adjust their ratings and price targets based on factors such as updated financial projections, clinical trial results, or other developments that could affect a company's future performance.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | ORIC Pharmaceuticals Soars 9.17% Pre-Market as Jefferies Raises Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | ORIC Pharmaceuticals Soars 9.17% Pre-Market as Jefferies Raises Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-19 22:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>ORIC Pharmaceuticals Inc. (ORIC) stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.</p>\n\n<p>Jefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.</p>\n\n<p>While the specific reasons behind Jefferies' price target increase were not disclosed, analysts typically adjust their ratings and price targets based on factors such as updated financial projections, clinical trial results, or other developments that could affect a company's future performance.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ORIC","symbol_name":"Oric Pharmaceuticals Inc.","start_time":0,"source_url":"","article_id":"1133311511","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133311511","pubTimestamp":1739975619,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"ORIC Pharmaceuticals Inc.  stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.Jefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.While the specific reasons behind Jefferies' price target increase","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ORIC":"Oric Pharmaceuticals Inc."},"translate_title":"Jefferies上调目标价，ORIC Pharmaceuticals盘前飙升9.17%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORIC":1},"content_text":"ORIC Pharmaceuticals Inc. (ORIC) stock surged 9.17% in pre-market trading on Wednesday, following a positive analyst action from Jefferies.\nJefferies, a leading financial services firm, raised its price target on ORIC stock to $22 from $18, reflecting increased optimism about the company's prospects. This bullish move by Jefferies analysts likely fueled investor interest and contributed to the significant pre-market rally in ORIC shares.\nWhile the specific reasons behind Jefferies' price target increase were not disclosed, analysts typically adjust their ratings and price targets based on factors such as updated financial projections, clinical trial results, or other developments that could affect a company's future performance.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}